Search fresh public links, source activity, and ready-to-use post angles for Inmune Bio.
Fresh curated links around INmune Bio are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The IT-X framework is designed to compare blood-based immune data across repeated measurements
While the immune reset field is mainly focused on depleting pathogenic B cells, ai3Bio is applying its novel approach to inflammatory T cells. The startup’s initial disease targets...
INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into...
Rather than deplete malfunctioning B cells as many other emerging autoimmune drugs do, Ai3Bio’s therapies are designed to eliminate a particular group of T helper cells.
Insider Brief PRESS RELEASE — INmune Bio Inc. (Nasdaq: INMB) and Quantum Computing Inc. (Nasdaq: QUBT) today announced a collaboration to apply quantum computing, artificial intell...
SEOUL, South Korea and COLOGNE, Germany, Oct. 22, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company dedicated to developing transformative ther...
Spanish researchers have developed a humanized monoclonal antibody, hB101.37, that inhibits the BAMBI pseudoreceptor and rebalances T cell immunity, showing therapeutic efficacy an...
A yeast-based supplement has given scientists a new way to examine how diet may influence the immune system’s ability to respond to cancer. In a study involving mice, researchers f...
IMU Biosciences and UK Biobank will profile 80,000 blood samples using technologies from Waters and Ultima Genomics, creating a high-resolution immune dataset to advance AI-driven...
North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific a...
INmune Bio (Nasdaq: INMB) and Quantum Computing Inc. (Nasdaq: QUBT) announced they are working togther to run INmune Bio’s clinical and preclinical data on XPro (XPro1595) through...
Eli Lilly-partnered TRexBio will apply the IPO proceeds toward clinical development of molecules designed to activate regulatory T cells to mediate immune responses and inflammatio...
Armed with $180 million and a dual-acting antibody for eczema, the startup is capitalizing on a change in sentiment that’s led to a sudden spike in reverse merger deals.
EnglishEl asma es una de las enfermedades más comunes en Estados Unidos y afecta a aproximadamente 11 de cada 100 mujeres. Es un trastorno crónico (a largo plazo) que causa la infl...
Researchers showed how optical metabolic imaging (OMI) can be used to characterize metabolic activity within immune cells from the peripheral blood of patients, which could potenti...
UConn Health study reveals a single-step ELISA approach can streamline Lyme disease testing SEATTLE, Sept. 17, 2026 /PRNewswire-PRWeb/ -- InBios International Inc., a leading devel...
SUZHOU, China, Oct. 22, 2026 /PRNewswire/ -- ImmVira Group ("ImmVira") today announced that updated clinical data from three bladder cancer studies of its lead oncolytic immunother...
A Baylor College of Medicine-led team combined high-throughput proteomics and AI-based structural prediction to discover and optimize a new class of molecular glues that degrade th...
The Miami Beach practice now uses quantified stem cell and extracellular vesicle products, along with an autologous option derived from the patient's own platelets.
A new review reveals how the unfolded protein response, a cellular stress-signalling network, helps tumours evade immune detection and could be targeted to boost cancer immunothera...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.